external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus.
Explore the latest updates from the life science industry.

Featured Articles.

BIOTECH

Shift Bioscience says better benchmarking could make AI “virtual cells” more useful for finding ageing drug targets

BIOPROCESSING

Bio-Rad Expands Foresight Pro Chromatography Columns for Biomanufacturing

PHARMA

How Automation is Accelerating Drug Discovery Timelines

HEALTH

The Eye's Hidden Drain, Discovered

PHARMA

EyePoint’s DURAVYU misses first Phase 3 endpoint in wet AMD, putting focus on second trial

HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

BIOTECH

Houdini Bio: tackling the gene-silencing barrier in genetic medicines

PHARMA

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

BIOPROCESSING

Bioreactors and Cell Culture Media: A Practical Comparison for Upstream Bioprocessing

Latest News.

31st October, 2026

01. London Set to Welcome Global Biotech Industry for London Biotechnology Show 2026

The London Biotechnology Show 2026 will return to ExCeL London on 18–19 November, bringing together biotechnology and pharmaceutical companies, researchers, healthcare professionals, investors, policymakers and technology providers to explore the breakthroughs and commercial opportunities shaping the future of life sciences.

17th October, 2026

02. BIX 2026 to explore the future of obesity treatments as full conference agenda is unveiled

BIOPLUS-INTERPHEX KOREA 2026 will bring together more than 300 companies and 90 industry experts in Seoul, with sessions spanning next-generation therapeutics, AI-driven drug development and global investment trends.

12th October, 2026

03. The Eye's Hidden Drain, Discovered

Researchers have found a lymphatic route that carries fluid and waste away from the back of the mouse eye, a discovery that could reshape how glaucoma and macular degeneration are studied, though any treatment is a long way off.

9th October, 2026

04. Shift Bioscience says better benchmarking could make AI “virtual cells” more useful for finding ageing drug targets

A new Nature Biotechnology paper argues that some genetic perturbation models were judged with poorly calibrated metrics, and the Cambridge company plans to use its fix to screen for rejuvenation and fibrosis targets.